Hongyan Guo

697 total citations
28 papers, 510 citations indexed

About

Hongyan Guo is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Hongyan Guo has authored 28 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Hongyan Guo's work include Natural product bioactivities and synthesis (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Lichen and fungal ecology (2 papers). Hongyan Guo is often cited by papers focused on Natural product bioactivities and synthesis (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Lichen and fungal ecology (2 papers). Hongyan Guo collaborates with scholars based in China, United States and Netherlands. Hongyan Guo's co-authors include Zhe‐Shan Quan, Liguo An, Hua Li, Qing‐Kun Shen, Hao Deng, Jinduo Yuan, Guiwen Yang, Yaoyao Zhu, Fumiao Zhang and Shijuan Shan and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Journal of Medicinal Chemistry and American Journal of Obstetrics and Gynecology.

In The Last Decade

Hongyan Guo

25 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongyan Guo China 12 171 143 90 79 57 28 510
Christopher C. Chadwick United States 14 263 1.5× 102 0.7× 105 1.2× 14 0.2× 73 1.3× 30 716
Shigeru Hoshiko Japan 15 386 2.3× 134 0.9× 88 1.0× 78 1.0× 202 3.5× 30 851
Márcio F.M. Alves Brazil 15 205 1.2× 29 0.2× 54 0.6× 18 0.2× 13 0.2× 20 557
Lilia I. Melnik United States 11 306 1.8× 44 0.3× 16 0.2× 12 0.2× 31 0.5× 18 562
Veena P. Salvi India 12 151 0.9× 95 0.7× 44 0.5× 3 0.0× 48 0.8× 16 486
Erica S. Lovelace United States 12 501 2.9× 116 0.8× 29 0.3× 30 0.4× 43 0.8× 15 749
Toshihiro Imaeda Japan 11 334 2.0× 245 1.7× 138 1.5× 6 0.1× 32 0.6× 20 597
Gill Dealtry South Africa 12 144 0.8× 93 0.7× 16 0.2× 7 0.1× 19 0.3× 20 405
Wanlong Zhu China 17 558 3.3× 124 0.9× 40 0.4× 380 4.8× 67 1.2× 39 809
Mohanapriya Arumugam India 13 158 0.9× 93 0.7× 77 0.9× 6 0.1× 22 0.4× 39 421

Countries citing papers authored by Hongyan Guo

Since Specialization
Citations

This map shows the geographic impact of Hongyan Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyan Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyan Guo more than expected).

Fields of papers citing papers by Hongyan Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongyan Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyan Guo. The network helps show where Hongyan Guo may publish in the future.

Co-authorship network of co-authors of Hongyan Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Hongyan Guo. A scholar is included among the top collaborators of Hongyan Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongyan Guo. Hongyan Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Lin, et al.. (2025). CD8+CD28+PD1− T Cells as a Prognostic Biomarker in Endometrial Cancer. Current Oncology. 32(3). 121–121. 2 indexed citations
2.
Guo, Hongyan, et al.. (2025). Recent advances in structural modifications of natural products for anti-leishmaniasis therapy (2010–2024). RSC Medicinal Chemistry. 16(11). 5268–5291. 1 indexed citations
3.
Wu, Ning, Ling Wei, Qiyu Liu, et al.. (2025). Extrachromosomal circular DNA expressing miRNA promotes ovarian cancer progression. Clinical and Translational Medicine. 15(9). e70445–e70445. 1 indexed citations
4.
Guo, Hongyan, et al.. (2024). Design and synthesis of forsythin derivatives as anti-inflammatory agents for acute lung injury. European Journal of Medicinal Chemistry. 267. 116223–116223. 3 indexed citations
5.
Shen, Qing‐Kun, et al.. (2024). Bioactivities and Structure-Activity Relationships of Usnic AcidDerivatives: A Review. Mini-Reviews in Medicinal Chemistry. 24(14). 1368–1384. 3 indexed citations
6.
Liu, Jinying, et al.. (2024). Cucurbitacin B and Its Derivatives: A Review of Progress in Biological Activities. Molecules. 29(17). 4193–4193. 3 indexed citations
7.
Liu, Zheng, Xing Huang, Hongyan Guo, et al.. (2023). Design, synthesis fusidic acid derivatives alleviate acute lung injury via inhibiting MAPK/NF-κB/NLRP3 pathway. European Journal of Medicinal Chemistry. 259. 115697–115697. 10 indexed citations
8.
Liu, Jinying, et al.. (2023). Research progress of natural products and their derivatives against Alzheimer’s disease. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2171026–2171026. 23 indexed citations
9.
Guo, Hongyan, et al.. (2023). Research status of indole-modified natural products. RSC Medicinal Chemistry. 14(12). 2535–2563. 23 indexed citations
10.
Li, Xiaoting, Hao Deng, Fen‐Er Chen, et al.. (2023). Panaxadiol carbamate derivatives: Synthesis and biological evaluation as potential multifunctional anti-Alzheimer agents. Bioorganic Chemistry. 143. 106977–106977. 7 indexed citations
11.
Cheng, Jie, Lína Zhang, Yiran Zhang, et al.. (2022). 3D spiral channels combined with flexible micro-sieve for high-throughput rare tumor cell enrichment and assay from clinical pleural effusion samples. Bio-Design and Manufacturing. 5(2). 358–370. 1 indexed citations
12.
Li, Jin, Zheng Liu, Fen‐Er Chen, et al.. (2022). In vitro and in vivo biological evaluation of newly synthesized multi-target 20(R)-panaxadiol derivatives for treating Alzheimer's disease. European Journal of Medicinal Chemistry. 244. 114825–114825. 8 indexed citations
13.
Huang, Xing, Lili Jin, Hao Deng, et al.. (2022). Research and Development of Natural Product Tanshinone I: Pharmacology, Total Synthesis, and Structure Modifications. Frontiers in Pharmacology. 13. 920411–920411. 19 indexed citations
14.
Guo, Hongyan, et al.. (2021). Piperazine skeleton in the structural modification of natural products: a review. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 1165–1197. 78 indexed citations
15.
Guo, Hongyan, et al.. (2019). Synthesis and Biological Evaluation of (+)-Usnic Acid Derivatives as Potential Anti-Toxoplasma gondii Agents. Journal of Agricultural and Food Chemistry. 67(34). 9630–9642. 25 indexed citations
16.
Zhang, Rui, Hongyan Guo, Yan Zhang, et al.. (2019). Establishment of a reference procedure to measure urine-formed elements and evaluation of an automated urine analyzer. Scandinavian Journal of Clinical and Laboratory Investigation. 79(8). 579–583.
17.
Feng, Juan, Jian Yang, Yu-Jun Chang, et al.. (2019). Caffeine-free hawk tea lowers cholesterol by reducing free cholesterol uptake and the production of very-low-density lipoprotein. Communications Biology. 2(1). 173–173. 24 indexed citations
18.
Feng, Juan, Wenlong Zhao, Ruijun Wang, et al.. (2018). Biological-Profiling-Based Systematic Analysis of Rhizoma Coptidis from Different Growing Regions and Its Anticholesterol Biosynthesis Activity on HepG2 Cells. Molecular Pharmaceutics. 15(6). 2234–2245. 5 indexed citations
19.
20.
Chan, John K., Daniel S. Kapp, Michael K. Cheung, et al.. (2008). Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer. American Journal of Obstetrics and Gynecology. 198(2). 216.e1–216.e5. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher C. Chadwick Breakdown of academic impact, for papers by Shigeru Hoshiko Breakdown of academic impact, for papers by Márcio F.M. Alves Breakdown of academic impact, for papers by Lilia I. Melnik Breakdown of academic impact, for papers by Veena P. Salvi Breakdown of academic impact, for papers by Erica S. Lovelace Breakdown of academic impact, for papers by Toshihiro Imaeda Breakdown of academic impact, for papers by Gill Dealtry Breakdown of academic impact, for papers by Wanlong Zhu Breakdown of academic impact, for papers by Mohanapriya Arumugam
Rankless by CCL
2026